0001415889-24-010677.txt : 20240410 0001415889-24-010677.hdr.sgml : 20240410 20240410203720 ACCESSION NUMBER: 0001415889-24-010677 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240408 FILED AS OF DATE: 20240410 DATE AS OF CHANGE: 20240410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kunkel Lori Anne CENTRAL INDEX KEY: 0001536368 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39247 FILM NUMBER: 24836934 MAIL ADDRESS: STREET 1: C/O PHARMACYCLICS, INC. STREET 2: 995 EAST ARQUES AVENUE CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enliven Therapeutics, Inc. CENTRAL INDEX KEY: 0001672619 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 811523849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-647-8519 MAIL ADDRESS: STREET 1: 6200 LOOKOUT ROAD CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: IMARA Inc. DATE OF NAME CHANGE: 20160419 3 1 form3-04112024_120413.xml X0206 3 2024-04-08 0 0001672619 Enliven Therapeutics, Inc. ELVN 0001536368 Kunkel Lori Anne C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD BOULDER CO 80301 true false false false Common Stock 14754 D Common Stock 31172 I See footnote Stock Option (right to buy) 1.12 2030-06-16 Common Stock 19699 D The shares are held by Lori Kunkel Revocable Trust DTD 11/08/2018 Lori A Kunkel TTEE. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020. Exhibit 24 - Power of Attorney /s/ Ben Hohl, by power of attorney 2024-04-10 EX-24 2 ex24-04112024_120414.htm ex24-04112024_120414.htm

POWER OF ATTORNEY


The undersigned, as a Section 16 reporting person of Enliven Therapeutics. Inc. (the “Company”),

hereby constitutes and appoints Ben Hohl, Galya Blachman and Frank Silanos. and each of them. As

the undersigned’s true and lawful attorney-in-fact to:


1. complete and execute Forms 3. 4 and 5 and other forms and all amendments thereto as such

attorney-in-fact shall in his discretion determine to be required or advisable pursuant to Section 16 of

the Securities Exchange Act of 1934 (as amended) and the rules and regulations promulgated

thereunder, or any successor laws and regulations, as a consequence of the undersigned’s ownership,

acquisition or disposition of securities of the Company; and


2. do all acts necessary in order to file such forms with the SEC, any securities exchange or national

association, the Company and such other person or agency as the attorneys-in-fact shall deem

appropriate.


The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agents shall do or

cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact

in serving in such capacity at the request of the undersigned. are not assuming. nor is the Company

assuming. any of the undersigned’s responsibilities to comply with Section 16 of the Securities

Exchange Act of 1934 (as amended).


This Power of Attorney shall remain in full force and effect until the undersigned is no longer

required to file Forms 3. 4 and 5 with respect to the undersigned’s holdings of and transactions in

securities issued by the Company, unless earlier revoked by the undersigned in a signed writing

delivered to the Company and the foregoing attorneys-in-fact.


IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of

this 4th day of April. 2024.



Signature:  /s/ Lori Kunkel


Print Name:  Lori Kunkel




-0-

Normal.dotm